tradingkey.logo

Sera Prognostics Inc

SERA
2.700USD
-0.390-12.62%
Close 11/06, 16:00ETQuotes delayed by 15 min
102.67MMarket Cap
LossP/E TTM

Sera Prognostics Inc

2.700
-0.390-12.62%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Sera Prognostics Inc

Currency: USD Updated: 2025-11-05

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sera Prognostics Inc's Score

Industry at a Glance

Industry Ranking
96 / 160
Overall Ranking
252 / 4616
Industry
Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Sera Prognostics Inc Highlights

StrengthsRisks
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Growing
The company is in a growing phase, with the latest annual income totaling USD 77.00K.
Fairly Valued
The company’s latest PE is -3.66, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 23.79M shares, decreasing 18.98% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.16M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.70.

Financial Health

Currency: USD Updated: 2025-11-05

The company's current financial score is 5.63, which is lower than the Professional & Commercial Services industry's average of 7.31. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 17.00K, representing a year-over-year decrease of 29.17%, while its net profit experienced a year-over-year decrease of 3.10%.

Score

Industry at a Glance

Previous score
5.63
Change
0

Financials

5.52

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

7.20

Operational Efficiency

2.57

Growth Potential

5.73

Shareholder Returns

7.11

Sera Prognostics Inc's Company Valuation

Currency: USD Updated: 2025-11-05

The company’s current valuation score is 6.75, which is lower than the Professional & Commercial Services industry's average of 7.13. Its current P/E ratio is -3.66, which is -77.20% below the recent high of -0.83 and -198.21% above the recent low of -10.90.

Score

Industry at a Glance

Previous score
6.75
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 96/160
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-05

The company’s current earnings forecast score is 9.00, which is higher than the Professional & Commercial Services industry's average of 7.66.

Score

Industry at a Glance

Previous score
9.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
0.000
Target Price
0.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

74
Total
5
Median
8
Average
Company name
Ratings
Analysts
Sera Prognostics Inc
SERA
2
PayPal Holdings Inc
PYPL
45
Block Inc
XYZ
45
Visa Inc
V
41
Fiserv Inc
FI
36
Global Payments Inc
GPN
32
1
2
3
...
15

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-05

The company’s current price momentum score is 6.65, which is lower than the Professional & Commercial Services industry's average of 7.17. Sideways: Currently, the stock price is trading between the resistance level at 3.73 and the support level at 2.68, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.44
Change
0.21

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.161
Neutral
RSI(14)
34.804
Neutral
STOCH(KDJ)(9,3,3)
4.793
Oversold
ATR(14)
0.268
Low Volatility
CCI(14)
-178.857
Sell
Williams %R
99.206
Oversold
TRIX(12,20)
0.167
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
3.058
Sell
MA10
3.327
Sell
MA20
3.276
Sell
MA50
3.210
Sell
MA100
2.904
Sell
MA200
3.182
Sell

Institutional Confidence

Currency: USD Updated: 2025-11-05

The company’s current institutional recognition score is 5.00, which is lower than the Professional & Commercial Services industry's average of 6.93. The latest institutional shareholding proportion is 64.14%, representing a quarter-over-quarter decrease of 23.01%. The largest institutional shareholder is The Vanguard, holding a total of 1.16M shares, representing 3.14% of shares outstanding, with 17.89% decrease in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Baker Bros. Advisors LP
5.50M
--
Whetstone Capital Advisors, LLC
3.63M
--
Chione, Ltd.
2.40M
+35.28%
abrdn Inc.
2.23M
+79.63%
Anthem, Inc.
2.20M
--
aMoon Fund
1.91M
-35.83%
Vivo Capital, LLC
1.65M
--
The Vanguard Group, Inc.
Star Investors
1.16M
-8.80%
Critchfield (Gregory C)
822.27K
+1.93%
AWM Investment Company, Inc.
680.93K
-21.45%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-05

The company’s current risk assessment score is 2.46, which is lower than the Professional & Commercial Services industry's average of 5.57. The company's beta value is 0.98. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.46
Change
0
Beta vs S&P 500 index
0.99
VaR
--
240-Day Maximum Drawdown
+83.03%
240-Day Volatility
+97.77%

Return

Best Daily Return
60 days
+15.53%
120 days
+106.57%
5 years
--
Worst Daily Return
60 days
-12.62%
120 days
-32.27%
5 years
--
Sharpe Ratio
60 days
+1.42
120 days
+0.80
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+83.03%
3 years
+87.25%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.67
3 years
+0.26
5 years
--
Skewness
240 days
+7.11
3 years
+9.64
5 years
--

Volatility

Realised Volatility
240 days
+97.77%
5 years
--
Standardised True Range
240 days
+11.82%
5 years
--
Downside Risk-Adjusted Return
120 days
+211.09%
240 days
+211.09%
Maximum Daily Upside Volatility
60 days
+81.87%
Maximum Daily Downside Volatility
60 days
+41.02%

Liquidity

Average Turnover Rate
60 days
+0.91%
120 days
+0.67%
5 years
--
Turnover Deviation
20 days
-70.40%
60 days
-22.80%
120 days
-43.58%

Peer Comparison

Professional & Commercial Services
Sera Prognostics Inc
Sera Prognostics Inc
SERA
6.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
S&P Global Inc
S&P Global Inc
SPGI
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CoreCivic Inc
CoreCivic Inc
CXW
8.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Huron Consulting Group Inc
Huron Consulting Group Inc
HURN
8.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brinks Co
Brinks Co
BCO
8.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Casella Waste Systems Inc
Casella Waste Systems Inc
CWST
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI